160 related articles for article (PubMed ID: 36164372)
1. E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer.
Ye X; Zhou J; Tong D; Wang D; Wang H; Guo J; Kang X
Dis Markers; 2022; 2022():8168517. PubMed ID: 36164372
[TBL] [Abstract][Full Text] [Related]
2. Identification of the interaction network of hub genes for melanoma treated with vemurafenib based on microarray data.
Quan L; Wang Y; Liang J; Shi J; Zhang Y; Tao K
Tumori; 2015; 101(4):368-74. PubMed ID: 25983087
[TBL] [Abstract][Full Text] [Related]
3. Digital gene expression profiling analysis and its application in the identification of genes associated with improved response to neoadjuvant chemotherapy in breast cancer.
Liu X; Jin G; Qian J; Yang H; Tang H; Meng X; Li Y
World J Surg Oncol; 2018 Apr; 16(1):82. PubMed ID: 29685151
[TBL] [Abstract][Full Text] [Related]
4. Genetic variations of DNA bindings of FOXA1 and co-factors in breast cancer susceptibility.
Wen W; Chen Z; Bao J; Long Q; Shu XO; Zheng W; Guo X
Nat Commun; 2021 Sep; 12(1):5318. PubMed ID: 34518541
[TBL] [Abstract][Full Text] [Related]
5. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
Vastrad B; Vastrad C; Tengli A; Iliger S
Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
Zheng H; Wang JJ; Yang XR; Yu YL
World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
[TBL] [Abstract][Full Text] [Related]
7. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.
Li S; Jiang F; Chen F; Deng Y; Pan X
J Biochem Mol Toxicol; 2022 Jan; 36(1):e22922. PubMed ID: 34964205
[TBL] [Abstract][Full Text] [Related]
8. PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.
Lee KY; Lee JW; Nam HJ; Shim JH; Song Y; Kang KW
Mol Cells; 2011 Jul; 32(1):107-11. PubMed ID: 21573702
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression.
Han R; Zhao J; Lu L
Oncol Rep; 2020 Jun; 43(6):2062-2072. PubMed ID: 32186770
[TBL] [Abstract][Full Text] [Related]
11. Feature genes in metastatic breast cancer identified by MetaDE and SVM classifier methods.
Tuo Y; An N; Zhang M
Mol Med Rep; 2018 Mar; 17(3):4281-4290. PubMed ID: 29328377
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer.
Bao Y; Wang L; Shi L; Yun F; Liu X; Chen Y; Chen C; Ren Y; Jia Y
Cell Mol Biol Lett; 2019; 24():38. PubMed ID: 31182966
[TBL] [Abstract][Full Text] [Related]
13. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
Li T; Gao X; Han L; Yu J; Li H
World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic Analysis of Breast Cancer Patients Sensitive and Resistant to Chemotherapy: Looking for Overall Survival and Drug Resistance Biomarkers.
Barrón-Gallardo CA; Garcia-Chagollán M; Morán-Mendoza AJ; Delgadillo-Cristerna R; Martínez-Silva MG; Aguilar-Lemarroy A; Jave-Suárez LF
Technol Cancer Res Treat; 2022; 21():15330338211068965. PubMed ID: 34981997
[TBL] [Abstract][Full Text] [Related]
15. KEGG-expressed genes and pathways in triple negative breast cancer: Protocol for a systematic review and data mining.
Chen J; Liu C; Cen J; Liang T; Xue J; Zeng H; Zhang Z; Xu G; Yu C; Lu Z; Wang Z; Jiang J; Zhan X; Zeng J
Medicine (Baltimore); 2020 May; 99(18):e19986. PubMed ID: 32358373
[TBL] [Abstract][Full Text] [Related]
16. The Overexpression of CD80 and ISG15 Are Associated with the Progression and Metastasis of Breast Cancer by a Meta-Analysis Integrating Three Microarray Datasets.
Li Y; Bai W; Zhang L
Pathol Oncol Res; 2020 Jan; 26(1):443-452. PubMed ID: 30411299
[TBL] [Abstract][Full Text] [Related]
17. [Identification of gene biomarkers to predict responses to neoadjuvant chemoradiotherapy in patients with rectal cancer and pathways enrichment analysis].
Wang XJ; Yu Q; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1183-1187. PubMed ID: 31874536
[No Abstract] [Full Text] [Related]
18. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
19. The bioinformatics analysis of quercetin in octagonal lotus for the screening of breast cancer MYC, CXCL10, CXCL11, and E2F1.
Ma Y; Peng Z; Pan R; Zhu Z; Meng X; Hu H; Qiao X; Huang X; Hou M
Int J Immunopathol Pharmacol; 2021; 35():20587384211040903. PubMed ID: 34693792
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1.
Xia L; Li F; Qiu J; Feng Z; Xu Z; Chen Z; Sun J
BMC Cancer; 2020 Oct; 20(1):949. PubMed ID: 33008330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
